Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids —clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole

To investigate the incidence of pneumocystis pneumonia (PCP) and its risk factors in patients with rheumatic disease receiving non-high-dose steroid treatment, along with the risks and benefits of PCP prophyla...
Source: Arthritis Research and Therapy - Category: Rheumatology Authors: Tags: Research article Source Type: research